Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q4 2015 (Next →)

Filing Date: Feb 8, 2016

Total Value ($000): $113,179 (100.0% shares, 0.0% debt)

Holdings (31)

— BLUEPRINT MEDICINES CORP 9.6%

Value ($000) $10,865 Shares 412,500 Est. Cost $26.34 Unrealized —

— SAGE THERAPEUTICS INC 7.4%

Value ($000) $8,338 Shares 143,011 Est. Cost $58.30 Unrealized —

— LOXO ONCOLOGY INC 6.3%

Value ($000) $7,155 Shares 251,500 Est. Cost $28.45 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 5.9%

Value ($000) $6,700 Shares 321,023 Est. Cost $15.82 Unrealized 0.0%

— SPARK THERAPEUTICS INC 5.8%

Value ($000) $6,570 Shares 145,000 Est. Cost $45.31 Unrealized —

— BLUEBIRD BIO INC 5.7%

Value ($000) $6,422 Shares 100,000 Est. Cost $64.22 Unrealized —

AGIO AGIOS PHARMACEUTICALS INC 5.5%

Value ($000) $6,265 Shares 96,500 Est. Cost $65.59 Unrealized 0.0%

— MYOKARDIA INC 5.2%

Value ($000) $5,921 Shares 403,872 Est. Cost $14.66 Unrealized —

— GENOMIC HEALTH INC 5.1%

Value ($000) $5,808 Shares 165,000 Est. Cost $35.20 Unrealized —

ILMN ILLUMINA INC 5.1%

Value ($000) $5,758 Shares 30,000 Est. Cost $161.39 Unrealized 0.0%

ALNY ALNYLAM PHARMACEUTICALS INC 5.0%

Value ($000) $5,648 Shares 60,000 Est. Cost $92.72 Unrealized 0.0%

— EPIZYME INC 4.7%

Value ($000) $5,327 Shares 332,500 Est. Cost $16.02 Unrealized —

VYGR VOYAGER THERAPEUTICS INC 4.6%

Value ($000) $5,187 Shares 236,862 Est. Cost $21.90 Unrealized —

ILMN ILLUMINA INC 3.4%

Value ($000) $3,839 Shares 20,000 Est. Cost $161.39 Unrealized 0.0%

BIIB BIOGEN INC 2.4%

Value ($000) $2,757 Shares 9,000 Est. Cost $287.35 Unrealized 0.0%

— FOUNDATION MEDICINE INC 2.1%

Value ($000) $2,422 Shares 115,000 Est. Cost $21.06 Unrealized —

— GENMARK DIAGNOSTICS INC 2.1%

Value ($000) $2,406 Shares 310,000 Est. Cost $7.76 Unrealized —

BMY BRISTOL MYERS SQUIBB CO 2.0%

Value ($000) $2,213 Shares 32,164 Est. Cost $46.69 Unrealized 0.0%

— GLOBAL BLOOD THERAPEUTICS IN 1.9%

Value ($000) $2,101 Shares 65,000 Est. Cost $32.32 Unrealized —

— INVITAE CORP 1.8%

Value ($000) $2,053 Shares 250,000 Est. Cost $8.21 Unrealized —

— KITE PHARMA INC 1.6%

Value ($000) $1,849 Shares 30,000 Est. Cost $61.63 Unrealized —

DXCM DEXCOM INC 1.2%

Value ($000) $1,392 Shares 17,000 Est. Cost $20.81 Unrealized 0.0%

— BLUEBIRD BIO INC 1.1%

Value ($000) $1,284 Shares 20,000 Est. Cost $64.22 Unrealized —

OSUR ORASURE TECHNOLOGIES INC 1.0%

Value ($000) $1,095 Shares 170,000 Est. Cost $5.71 Unrealized 0.0%

— OXFORD IMMUNOTEC GLOBAL PLC 0.8%

Value ($000) $863 Shares 75,000 Est. Cost $11.51 Unrealized —

— JUNO THERAPEUTICS INC 0.7%

Value ($000) $769 Shares 17,500 Est. Cost $43.94 Unrealized —

— ATARA BIOTHERAPEUTICS INC 0.6%

Value ($000) $660 Shares 25,000 Est. Cost $26.40 Unrealized —

— MEDIDATA SOLUTIONS INC 0.4%

Value ($000) $493 Shares 10,000 Est. Cost $49.30 Unrealized —

— TROVAGENE INC 0.3%

Value ($000) $378 Shares 70,000 Est. Cost $5.40 Unrealized —

AGIO AGIOS PHARMACEUTICALS INC 0.3%

Value ($000) $325 Shares 5,000 Est. Cost $65.59 Unrealized 0.0%

— FOUNDATION MEDICINE INC 0.3%

Value ($000) $316 Shares 15,000 Est. Cost $21.06 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	BLUEPRINT MEDICINES CORP	412,500	$10,865	9.6%	$26.34	—	COM	09627Y109
—	SAGE THERAPEUTICS INC	143,011	$8,338	7.4%	$58.30	—	COM	78667J108
—	LOXO ONCOLOGY INC	251,500	$7,155	6.3%	$28.45	—	COM	548862101
CTMX	CYTOMX THERAPEUTICS INC	321,023	$6,700	5.9%	$15.82	0.0%	COM	23284F105
—	SPARK THERAPEUTICS INC	145,000	$6,570	5.8%	$45.31	—	COM	84652J103
—	BLUEBIRD BIO INC	100,000	$6,422	5.7%	$64.22	—	COM	09609G100
AGIO	AGIOS PHARMACEUTICALS INC	96,500	$6,265	5.5%	$65.59	0.0%	COM	00847X104
—	MYOKARDIA INC	403,872	$5,921	5.2%	$14.66	—	COM	62857M105
—	GENOMIC HEALTH INC	165,000	$5,808	5.1%	$35.20	—	COM	37244C101
ILMN	ILLUMINA INC	30,000	$5,758	5.1%	$161.39	0.0%	COM	452327109
ALNY	ALNYLAM PHARMACEUTICALS INC	60,000	$5,648	5.0%	$92.72	0.0%	COM	02043Q107
—	EPIZYME INC	332,500	$5,327	4.7%	$16.02	—	COM	29428V104
VYGR	VOYAGER THERAPEUTICS INC	236,862	$5,187	4.6%	$21.90	—	COM	92915B106
ILMN	ILLUMINA INC	20,000	$3,839	3.4%	$161.39	0.0%	Call	452327109
BIIB	BIOGEN INC	9,000	$2,757	2.4%	$287.35	0.0%	COM	09062X103
—	FOUNDATION MEDICINE INC	115,000	$2,422	2.1%	$21.06	—	COM	350465100
—	GENMARK DIAGNOSTICS INC	310,000	$2,406	2.1%	$7.76	—	COM	372309104
BMY	BRISTOL MYERS SQUIBB CO	32,164	$2,213	2.0%	$46.69	0.0%	COM	110122108
—	GLOBAL BLOOD THERAPEUTICS IN	65,000	$2,101	1.9%	$32.32	—	COM	37890U108
—	INVITAE CORP	250,000	$2,053	1.8%	$8.21	—	COM	46185L103
—	KITE PHARMA INC	30,000	$1,849	1.6%	$61.63	—	COM	49803L109
DXCM	DEXCOM INC	17,000	$1,392	1.2%	$20.81	0.0%	COM	252131107
—	BLUEBIRD BIO INC	20,000	$1,284	1.1%	$64.22	—	Call	09609G100
OSUR	ORASURE TECHNOLOGIES INC	170,000	$1,095	1.0%	$5.71	0.0%	COM	68554V108
—	OXFORD IMMUNOTEC GLOBAL PLC	75,000	$863	0.8%	$11.51	—	ORD SHS	G6855A103
—	JUNO THERAPEUTICS INC	17,500	$769	0.7%	$43.94	—	COM	48205A109
—	ATARA BIOTHERAPEUTICS INC	25,000	$660	0.6%	$26.40	—	COM	046513107
—	MEDIDATA SOLUTIONS INC	10,000	$493	0.4%	$49.30	—	COM	58471A105
—	TROVAGENE INC	70,000	$378	0.3%	$5.40	—	COM NEW	897238309
AGIO	AGIOS PHARMACEUTICALS INC	5,000	$325	0.3%	$65.59	0.0%	Call	00847X104
—	FOUNDATION MEDICINE INC	15,000	$316	0.3%	$21.06	—	Call	350465100